Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CGEM

Cullinan Therapeutics Inc

Apr 30 • 04:00PM ET

13.05

+0.20 1.56 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: GILD INCY JAZZ NVAX KURA EXEL BPMC KPTI ESPR ONCY

| Held by: VTI XBI IWM VXF IWN IBB VTWO SCHA DFAS DFMC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.72	Insider Own	26.57%	Shs Outstand	60.24M	Perf Week	0.77%
Market Cap	801.94M	Forward P/E	-	EPS next Y	-2.77	Insider Trans	0.34%	Shs Float	44.45M	Perf Month	-8.16%
Enterprise Value	426.72M	PEG	-	EPS next Q	-0.84	Inst Own	81.06%	Short Float	18.26%	Perf Quarter	9.48%
Income	-219.88M	P/S	-	EPS this Y	6.95%	Inst Trans	2.14%	Short Ratio	10.19	Perf Half Y	53.71%
Sales	0.00M	P/B	1.92	EPS next Y	11.30%	ROA	-41.04%	Short Interest	8.11M	Perf YTD	26.09%
Book/sh	6.78	P/C	2.12	EPS next 5Y	6.53%	ROE	-44.02%	52W High	16.74 -22.04%	Perf Year	57.61%
Cash/sh	6.15	P/FCF	-	EPS past 3/5Y	- -25.62%	ROIC	-53.55%	52W Low	5.68 129.75%	Perf 3Y	34.12%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.24% 5.89%	Perf 5Y	-59.80%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-18.75%	Oper. Margin	-	ATR (14)	0.82	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.25	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	41.68	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.25	EPS Q/Q	-5.31%	SMA20	-7.77%	Beta	-0.09	Target Price	32.27
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-8.13%	Rel Volume	0.47	Prev Close	12.85
Employees	109	LT Debt/Eq	0.00	Earnings	Mar 10 BMO	SMA200	27.30%	Avg Volume	796.14K	Price	13.05
IPO	Jan 08, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.87% -100.00%	Trades		Volume	377,765	Change	1.56%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)